Market revenue in 2023 | USD 84.8 million |
Market revenue in 2030 | USD 169.6 million |
Growth rate | 10.4% (CAGR from 2023 to 2030) |
Largest segment | Peanuts |
Fastest growing segment | Peanuts |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dairy Products, Poultry Product, Tree Nuts, Peanuts, Shellfish, Wheat, Soys, Other |
Key market players worldwide | Allergy Therapeutics PLC, Church & Dwight Co Inc, Astellas Pharma Inc, Nestle SA, Aravax, Immunomic Therapeutics, Camallergy Inc, Rising Farms |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to food allergy market will help companies and investors design strategic landscapes.
Peanuts was the largest segment with a revenue share of 26.65% in 2023. Horizon Databook has segmented the Australia food allergy market based on dairy products, poultry product, tree nuts, peanuts, shellfish, wheat, soys, other covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia food allergy market, including forecasts for subscribers. This country databook contains high-level insights into Australia food allergy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account